- Details
- Description
Packaging Size:
30 capsules
Strength:
1 mg
Composition:
Talazoparib 1 mg (equivalent to the active talazoparib component)
Treatment:
Targeted treatment for certain BRCA-mutated, HER2-negative locally advanced or metastatic breast cancers. It is also used in combination with enzalutamide for certain HRR gene-mutated metastatic castration-resistant prostate cancers
Form:
Hard capsule for oral use
Brand:
Talaparib 1 mg
Quantity Unit:
Capsule
Manufacturer:
Everest Pharmaceuticals Ltd.
Talaparib 1 mg (Talazoparib) is an oral targeted anticancer medicine belonging to the PARP inhibitor class. It works by blocking PARP enzymes involved in DNA repair, which can cause certain cancer cells to die. It is primarily used for treating HER2-negative breast cancer with specific BRCA gene mutations and may be prescribed for other approved indications depending on the patient and country. Talaparib should be used under the supervision of an oncologist.
Therapeutic class: PARP inhibitor / targeted anticancer therapy.
Related Products
